menu
    • menu

    Company profile for Congenica

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Congenica is the provider of the diagnostic decision support platform, Sapientia, and associated clinical services, which enable clinicians to interrogate the human genome to identify disease-causing variants. Congenica aims to revolutionize personalized patient care through accurate diagnoses, curation of evolving knowledge bases, and support in clinical trials and drug development. 80% of rare diseases are thought to have a ...
    Congenica is the provider of the diagnostic decision support platform, Sapientia, and associated clinical services, which enable clinicians to interrogate the human genome to identify disease-causing variants. Congenica aims to revolutionize personalized patient care through accurate diagnoses, curation of evolving knowledge bases, and support in clinical trials and drug development. 80% of rare diseases are thought to have a genetic component, and patients wait an average of 4.7 years, and typically see 7.3 different clinical specialists, before getting a diagnosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CongenicaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9 E. Loockerman Street Suite 311, Dover, County of Kent, DE 19901,
    Telephone
    Telephone
    +1-800-721-0210
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.congenica.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/congenica?trk=company_logo
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Congenica

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Congenica Announces Partnership With Avesthagen
    Congenica Announces Partnership With Avesthagen

    11 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220810005487/en

    BUSINESSWIRE
    11 Aug 2022
    Share Share
    GenomOncology, Congenica announce collaborative development
    GenomOncology, Congenica announce collaborative development

    04 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/genomoncology-and-congenica-announce-collaborative-development-of-novel-precision-oncology-solution-301598373.html

    PRNEWSWIRE
    04 Aug 2022
    Share Share
    Congenica Appoints Robert Denison as CEO
    Congenica Appoints Robert Denison as CEO

    22 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220621005984/en

    BUSINESSWIRE
    22 Jun 2022
    Share Share
    Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
    Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

    03 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/03/2434146/0/en/Congenica-Appoints-Dr-Tom-Barber-as-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    03 May 2022
    Share Share
    Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
    Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

    03 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/03/2434367/0/en/Congenica-Appoints-Dr-Tom-Barber-as-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    03 May 2022
    Share Share
    Congenica to Provide Tertiary Analysis for Whole Genome Sequencing
    Congenica to Provide Tertiary Analysis for Whole Genome Sequencing

    16 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/16/2404059/0/en/Congenica-to-Provide-Tertiary-Analysis-for-Whole-Genome-Sequencing-for-Hong-Kong-Genome-Project.html

    GLOBENEWSWIRE
    16 Mar 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search